🎯 Mission & Policies

Read this first, every time

This is the constitution of Indexa. Before any agent or chat plans a campaign, books a cost, restocks, or pays out cash, it reasons from this document. It answers two questions: what are we maximising (the mission) and what are we never allowed to do to get there (the policies). Everything else in the vault — the Driver Tree, the Agent Operating Manual, the SOPs — exists to execute this.

---

1. The Mission

Turn a small pool of capital into a durable, cash-generating peptide business — by compounding three things every cycle: stock, customers, and cash — without ever breaking the research-use trust the brand is built on.

We are not optimising for a single big month. We are building a machine that throws off more cash than it consumes, every cycle, and gets cheaper to run over time. Each ringgit of profit is a worker: in the early stages it goes back to work buying stock and assets; only once the machine is self-sufficient does it start paying the owner.

What “growth” means here (the objective function)

The agent maximises, in priority order:

1. Survival — never run out of cash, never stock out a top-seller, never break the research-use guardrail. A dead business grows nothing.
2. Compounding net worth — cash + inventory-at-cost + productive assets, growing cycle over cycle.
3. Resilience — more customers, more agents, more channels, so no single seller or SKU is the business.
4. Margin & efficiency — same revenue, lower cost to produce and fulfil it, every quarter.
5. Owner yield — sustainable salary + savings, but only after the machine can fund its own next cycle.

The rule the whole mission rests on

Grow from margin, not from borrowing or from the owner’s pocket. After the seed capital, the business funds itself. If a cycle can’t fund the next one, that’s the #1 problem to fix — before any new spend.

---

2. What this business is worth (real, reconciled 2026-06-01)

These are reconciled actuals from the Stock & Revenue Reconciliation — not the old seeded estimates. Stock ledger ties to the physical shelf; revenue ties to the bank.

Performance to date (Mar–May 2026, cumulative)

Line	RM	Note
Revenue collected	12,950	Muz 12,030 · Kio 370 · Haikhal 150 · Najiha 400 — all paid
COGS of units sold	4,387	peptides sold × landed cost
Gross profit	8,563	~66% gross margin
Logged opex	small	Lovable RM105/mo · Reta consumables RM283; Janoshik COA, domain, phone not yet logged
Free / personal stock given (at cost)	~1,078	trials + own use — below the line (marketing / owner-draw)

Balance-sheet snapshot

Component	RM	Source
Cash generated	≈ 7,855	revenue 12,950 − batch 3 (4,285) − all real costs (812: Janoshik, Lovable, domain, shipping)
Inventory at cost	≈ 1,437	7 real SKUs × unit_cost (see table below)
Receivables	0	Muz fully settled
Productive assets	~0	none owned yet
≈ Business value	≈ 9,292	cash + inventory
Capital put in (returned ✅)	3,624	the first 2 batches — the only money ever poured in, already repaid to founder
≈ Multiple on capital	≈ 2.56×	business value ÷ capital in
Retained business profit	≈ 4,230	the part beyond returning your capital — business money, partly drawn for personal emergencies (founder loan)

The honest position

The business collected RM12,950, runs on ≈ RM28/month fixed cost, and has generated ≈ RM7,855 cash + RM1,437 inventory from RM3,624 in (2.56×). Your RM3,624 capital is already repaid. The RM4,230 retained profit is business money — meant to fund the next restock — but has been partly used for personal emergencies. The exact draw is the only number left to close the founder ↔ company balance. See Stock & Revenue Reconciliation Part D.

Inventory at cost — the 7 real SKUs

SKU	On hand	Unit cost	At cost (RM)
Retatrutide 60mg	4	133	532
CJC-1295 5mg (R&D hold)	9	26	234
TB500 5mg	6	39	234
BPC-157 10mg	5	40	200
SS-31 10mg	3	44	132
MOTS-C 10mg	3	35	105
GHK-Cu 100mg	0	26	0
Total			≈ 1,437

Most liquid: the 4 Reta vials = RM1,600 at dropship (RM400), plus 5 BPC-157 10mg + 6 TB500 5mg that can build up to 5 Wolverine blends (RM350 each). Reta is the engine — restocking it is the priority (Stage 1).

---

3. The Growth-Stage Ladder (draft — tune the thresholds)

This is the capital plan: how cash gets allocated changes as the business matures. The agent always knows which stage we’re in and allocates accordingly. Stages gate on conditions, not dates.

The principle

Early on, the business eats everything it earns to get stronger. The owner gets paid only once the machine can refill its own stock, cover its own costs, and still have a buffer. Don’t skip stages to pull money early — that starves the compounding.

Stage 0 — Seed ✅ (done)

RM3,500 in. Store live, first stock bought, first agents (Muz, Haikhal) selling. We are past this.

Stage 1 — Compound Stock & Buffer 🔵 (WE ARE HERE)

Allocation: ~100% of net cash recycled. No owner salary yet.

• Priority 1: restock top-sellers so they never hit reorder_point (Reta, BPC-157 5mg, GHK-Cu).
• Priority 2: complete the price ladder (R10/R20/R30 public + dropship) so we capture every dose-tier of demand.
• Priority 3: build a cash buffer.
• Exit when: cash buffer ≥ RM10,000 and no top-seller has stocked out for 60 days and ≥ 4 active agents (de-risk the Muz concentration). (Adjust these.)

Stage 2 — Build Capability & Lower Cost 🟡

The machine learns to run cheaper and look more premium. Allocation: ~60% restock · ~30% productive assets · ~10% savings reserve.

• Productive assets = the things that permanently lower cost or raise price power: in-house packaging/3D-printing, owned brand & label kit, dedicated marketing/ad accounts, photography. (See the brand-improvement pipeline in Distribution — Growth Path.)
• Goal: lowest-cost, self-sufficient operation with deep stock — fulfil in-house, look research-grade, stop paying others for what we can own.
• Exit when: core assets acquired, COGS + opex per unit has visibly dropped, and monthly net is consistently ≥ RM3,000 for 3 months. (Adjust.)

Stage 3 — Pay the Owner & Save 🟢

Operation runs lean on deep stock. Now the machine yields. Allocation per cycle: ~50% restock & growth · owner salary · ~15% business savings · ~10% opportunistic (new SKUs / new markets).

• Owner salary target: RM2,000/month (set by founder). Paid as a regular owner-draw line, not an ad-hoc withdrawal. RM2,000 is the first draw the business must be able to cover, every month, before savings/growth — it’s the wage for the founder doing 100% of operations today (sourcing, recon & prep, COA via Janoshik, QC, finance).
• Business savings is an untouchable reserve = ≥ 3 months of opex as a floor.

Solo-operator reality

The founder is currently the entire operation — sourcing/supplying, reconstitution & prep, getting product COA-tested (Janoshik), quality control, and bookkeeping. The RM2,000 salary is the cost of that labour; until the business reliably covers it and its own restock, that labour is effectively un-paid equity. Reducing this single-person dependency is a Stage 2–3 goal (document SOPs so steps can be handed off), separate from the seller-concentration risk on the distribution side.

Stage 4 — Scale & De-risk 🟣

Diversified agents (no single seller > ~30% of revenue), multi-channel demand, reserve ≥ 6 months opex. Reinvest into scaling the agent network and product range; structured owner salary + profit distribution. The business is now an asset that could run without daily owner input.

Stage discipline

The agent must not propose an owner draw while in Stage 1–2, and must not advance a stage until every exit condition is met. If asked to pull cash early, surface the stage rule and the trade-off, then escalate to the owner.

---

4. Cash Allocation Waterfall (applies every cycle, every stage)

When cash comes in, it’s allocated top-down — a lower priority never gets funded before a higher one is satisfied:

1. Restock reserve — set aside enough to refill any top-seller before it stocks out. (Lost sales are the most expensive thing we can do.)
2. Fixed burn / runway — cover the known monthly opex (Lovable RM105/mo, Cursor, domain, phone, payment fees, base shipping) and keep ≥ 1 month ahead.
3. Stage allocation — apply the current stage’s split (assets / savings / owner) from §3.
4. Growth spend — ads, agent recruitment, new SKUs — funded from what remains, sized so ROAS stays ≥ 2.0.

---

5. Operating Policies (non-negotiables — the agent obeys these without asking)

These extend the principles in the Agent Operating Manual. Where this charter and any other note disagree, this charter wins.

Money & truth

• Never invent a number. Money, stock, and IDs come from the website/Supabase, the bank, or the owner. Unknown → leave blank and flag.
• Everything on the books. Every ringgit in or out is a #transaction. Nothing off-ledger, ever.
• Reconcile weekly. The vault must match the bank. Unreconciled count trends to zero.
• Recognise revenue when paid; book COGS when stock ships. Don’t count a cart as a sale.
• Separate business cash from personal. Owner money out is always an explicit owner-draw.

Growth & risk

• Fund growth from margin, not borrowing. No debt, no dipping into the owner’s pocket after seed.
• Protect the buffer. Never spend below the current stage’s restock reserve + runway floor.
• De-risk concentration. Treat dependence on a single seller (Muz) or single SKU (Reta) as a standing risk to reduce, not a comfort.
• ROAS ≥ 2.0 on any paid channel, or pause and diagnose.

Brand & compliance (the trust moat — breaking this can end the business)

• Research-use framing only. No human dosing, no medical/therapeutic claims, in any customer-facing output — by the agent, the owner, or any reseller selling under our name.
• COA / Verify is the proof, always. Lead with third-party test reports; it’s our edge over competitors like Olymp Peptides.
• Two prices, never crossed. Public price on the storefront; dropship price only to vetted resellers. Never quote the wrong tier (see Pricing Model).

Escalate, don’t guess

Stop and ask the owner on: any owner draw outside the stage rule, refunds/chargebacks, price or bundle changes, a stage advance, a top-seller stockout or supplier delay, any single cash movement > RM1,000, anything that won’t reconcile, or any message touching medical/dosing/legal territory.

---

6. How this connects to execution

Mission & Policies  (what to maximise + what's forbidden)   ← you are here
        │
        ▼
Value Architecture — Driver Tree  (which numbers move the mission, and the lever for each)
        │
        ▼
Agent Operating Manual + SOPs  (the routines that pull those levers)
        │
        ▼
Log notes + Bases  (the live numbers that prove it worked)

• 🌳 Value Architecture — Driver Tree — the decomposition of business value into the levers an agent can actually pull.
• 🤖 Agent Operating Manual — daily/weekly/monthly routines.
• 📊 KPI Dashboard — the live scoreboard.
• 🟣 Distribution — Growth Path · 🟠 Operation — Playbook · 🟢 Capital — Playbook

Owner refinement needed

The bold thresholds in §3 (RM10k buffer, 4 agents, RM3k net, savings months) and the stage allocation splits are first-draft proposals built from real numbers. Adjust them to your targets — once set, the agent treats them as policy.